Applied Machine Learning Scientist at Unlearn AI

San Francisco, California, United States

Unlearn AI Logo
$140,000 – $165,000Compensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Artificial Intelligence, SoftwareIndustries

Requirements

Candidates must possess a Bachelor of Science degree in computer science, engineering, physics, mathematics, or a related field. A minimum of 2 years of experience in developing and adapting machine learning models for real-world problems is required, along with demonstrable software engineering fundamentals. Fluency in the Python machine learning and data science ecosystem and evidence of successful ML project execution in an academic or industrial setting are also necessary.

Responsibilities

The Applied Machine Learning Scientist will design and implement machine learning models to characterize and predict disease progression. They will apply and fine-tune proprietary architectures to real-world clinical data, clearly communicate technical findings to stakeholders, and stay updated on ML developments. Additionally, they will represent Unlearn to the broader scientific community.

Skills

Machine Learning
Generative AI
AI Forecasting
Clinical Trials
Software Development
Experimentation
Problem-Solving
Team Collaboration

Unlearn AI

Creates AI-driven digital twins for healthcare

About Unlearn AI

Unlearn.AI creates digital twins of patients using artificial intelligence, which are virtual replicas that simulate potential health outcomes. This technology allows healthcare providers to predict how a patient's health may change over time, leading to more informed treatment decisions. The primary clients include healthcare providers and pharmaceutical companies, who can use these digital twins in clinical trials to simulate control groups, potentially speeding up drug development and approval processes. Unlearn.AI differentiates itself by offering a unique simulation technology that reduces the need for actual human control groups, which can save time and resources. The company's goal is to enhance decision-making in patient care and drug development through precise health outcome predictions.

San Francisco, CaliforniaHeadquarters
2017Year Founded
$127.1MTotal Funding
SERIES_CCompany Stage
AI & Machine Learning, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Paid Holidays
Commuter Benefits
Paid Parental Leave
Company Equity

Risks

Over-reliance on AI data may lead to inaccuracies in trial outcomes.
Increased competition from companies like Consilx and Aicure could impact market share.
High clinical trial failure rates could affect perception of Unlearn AI's effectiveness.

Differentiation

Unlearn AI's TwinRCT uses digital twins to enhance clinical trial precision.
The company offers TrialPioneer, a free tool for innovative trial design exploration.
Unlearn AI's digital twin technology reduces the need for human control groups.

Upsides

AI in clinical trials market expected to reach $2.74 billion by 2030.
Partnership with ProJenX highlights AI's potential in specific therapeutic areas.
TwinRCT 3.0 enhances decision-making in Phase II trials for better outcomes.

Land your dream remote job 3x faster with AI